CRISPR-Cas CLINICAL TRIALS

All | TALENS | ZFN

Antibacterial

Indicator
IND Enabling
Phase I
Phase II
Phase III

Blood

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Human Immunodeficiency Virus Infection, HIV, (NCT03164135)
Sponsors:

Affiliated Hospital to Academy of Military Medical Sciences

IND Enabling
Phase I
Phase II
Phase III

Cancer

Nasopharyngeal Carcinoma, (NCT03044743)
Sponsors:

Yang Yang, MD, PhD, MSCR, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Solid Tumor Adult, (NCT03747965)
Sponsors:

Chinese PLA General Hospital

Indicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Multiple Solid Tumor Adult, (NCT03545815)
Sponsors:

Chinese PLA General Hospital

Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
B Cell Lymphoma, (NCT03166878)
Sponsors:

Chinese PLA General Hospital

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III

Eye

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III

Metabolic disorder